Why Sutro, Lumos And More Health Care Stocks Are Moving Today
Sabra Health Care REIT (NASDAQ: SBRA) shares are trading higher on Thursday after JMP Securities upgraded the stock from Market Perform to Market Outperform and announced a price target of $24 per share.
Sabra Health Care REIT Inc is a health care facility real estate investment trust. The company operates one segment that owns and invests in health care real estate.
Sabra Health Care REIT shares were trading up 2.58% at $17.66 at the time of publication on Thursday. The stock has a 52-week high of $22.54 and a 52-week low of $5.54.
Sutro Biopharma (NASDAQ: STRO) shares are trading higher after Stifel initiated coverage on the stock with a Buy rating and a price target of $25 per share.
Sutro Biopharma is a clinical-stage company developing and manufacturing therapeutics. Primarily focused on next generation cancer and autoimmune therapeutics — antibody conjugates, bispecific antibodies and cytokine derivatives.
Sutro Biopharma shares were trading up 2.69% at $16.79. The stock has a 52-week high of $19.18 and a 52-week low of $6.
Enlivex Therapeutics (NASDAQ: ENLV) shares are trading higher after the company reported "positive" interim results of an investigator-initiated Phase II clinical trial evaluating Allocetra in severe COVID-19 patients.
Enlivex Therapeutics is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing allogeneic drug pipeline for rebalancing immune hyper-responses.
Enlivex Therapeutics shares were trading up 43.53% at $11.87. The stock has a 52-week high of $16.94 and a 52-week low of $3.59.
Lumos Pharma (NASDAQ: LUMO) shares are trading higher after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating and a price target of $32 per share.
Lumos Pharma is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells.
Lumos Pharma shares were trading up 6.07% at $16.31. The stock has a 52-week high of $32.40 and a 52-week low of $6.74.
Omega Healthcare Investors (NYSE: OHI) shares are trading higher after JMP Securities upgraded the stock from Market Perform to Market Outperform and announced a price target of $43 per share.
Omega Healthcare Investors is a health care facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term health care facilities.
Omega Healthcare Investors shares were trading up 2.12% at $37.63. The stock has a 52-week high of $45.22 and a 52-week low of $13.33.
See more from Benzinga
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
